Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 2,774 $ 1,347 $ 205,964,847 $ (182,547,265) $ 253,734 $ (5,281,180) $ 18,394,257
Beginning balance, shares at Dec. 31, 2021 2,774,394 1,346,661          
Issuance of common stock in connection with purchase of in-process research and development $ 88 804,912 805,000
Issuance of common stock in connection with purchase of in-process research and development, shares   87,500          
Share-based expense 255,465 255,465
Exercise of purchase warrants
Exercise of purchase warrants, shares   199          
Net loss (4,265,801) (4,265,801)
Ending balance, value at Jun. 30, 2022 $ 2,774 $ 1,435 207,025,224 (186,813,066) 253,734 (5,281,180) 15,188,921
Ending balance, shares at Jun. 30, 2022 2,774,394 1,434,360          
Beginning balance, value at Mar. 31, 2022 $ 2,774 $ 1,347 206,084,442 (184,140,876) 253,734 (5,281,180) 16,920,241
Beginning balance, shares at Mar. 31, 2022 2,774,394 1,346,830          
Issuance of common stock in connection with purchase of in-process research and development $ 88 804,912 805,000
Issuance of common stock in connection with purchase of in-process research and development, shares   87,500          
Share-based expense 135,870 135,870
Exercise of purchase warrants
Exercise of purchase warrants, shares   30          
Net loss (2,672,190) (2,672,190)
Ending balance, value at Jun. 30, 2022 $ 2,774 $ 1,435 207,025,224 (186,813,066) 253,734 (5,281,180) 15,188,921
Ending balance, shares at Jun. 30, 2022 2,774,394 1,434,360          
Beginning balance, value at Dec. 31, 2022 $ 2,774 $ 1,520 $ 207,769,904 $ (189,099,618) $ 253,734 $ (5,281,180) $ 13,647,134
Beginning balance, shares at Dec. 31, 2022 2,774,394 1,519,360          
Issuance of common stock to adjust for reverse split rounding 0 16 (16) 0 0 0 0
Issuance of common stock to adjust for reverse split rounding, shares   15,941          
Share-based expense $ 138,241 $ 138,241
Net loss (1,907,517) (1,907,517)
Ending balance, value at Jun. 30, 2023 $ 2,774 $ 1,536 207,908,129 (191,007,135) 253,734 (5,281,180) 11,877,858
Ending balance, shares at Jun. 30, 2023 2,774,394 1,535,301          
Beginning balance, value at Mar. 31, 2023 $ 2,774 $ 1,520 $ 207,838,756 $ (189,956,172) $ 253,734 $ (5,281,180) $ 12,859,432
Beginning balance, shares at Mar. 31, 2023 2,774,394 1,519,360          
Issuance of common stock to adjust for reverse split rounding 0 16 (16) 0 0 0 0
Issuance of common stock to adjust for reverse split rounding, shares   15,941          
Share-based expense $ 69,389 $ 69,389
Net loss (1,050,963) (1,050,963)
Ending balance, value at Jun. 30, 2023 $ 2,774 $ 1,536 $ 207,908,129 $ (191,007,135) $ 253,734 $ (5,281,180) $ 11,877,858
Ending balance, shares at Jun. 30, 2023 2,774,394 1,535,301